Bruker (NASDAQ:BRKR) PT Lowered to $65.00

Bruker (NASDAQ:BRKR – Free Report) had its price objective decreased by JPMorgan Chase & Co. from $70.00 to $65.00 in a research report sent to investors on Tuesday morning, Benzinga reports. JPMorgan Chase & Co. currently has a neutral rating on the medical research company’s stock. Separately, StockNews.com began coverage on Bruker in a research […]

Related Keywords

United States ,Frankh Laukien , ,Bruker Energy Supercon Technologies ,Us Bancorp ,First Republic Investment Management Inc ,Securities Exchange Commission ,Bruker Corporation ,Bruker Company Profile ,Jpmorgan Chase Co ,Advisors Inc ,Free Report ,Stock Down ,Get Free Report ,Exchange Commission ,Republic Investment Management ,Finance Advisors ,Bruker Scientific Instruments ,Bruker Energy ,Bruker Daily ,Bruker ,Nasdaq Brkr ,Brkr ,Computer And Technology ,11679410 ,Lower Price Target ,